Search clinical trials for: Bixa orellana

Total 26 results

University of Nove de Julho

Not yet recruiting

Antimicrobial Photodynamic Therapy as an Adjunct for Management of Deep Caries Lesions

Caries
Universidad de Antioquia
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)

Completed

Evaluation of Egg Consumption and Its Enrichment With Annatto on Cardiovascular Risk and Satiety in Healthy Adults (EGGANT)

Healthy Volunteers

Colombia
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial. (TOCANNATO)

Breast Cancer

Italy
Natural Origins
Universidad Politecnica de Madrid

Completed

Effects of Exten(d) Supplementation on Training Ability in Recreational Runners (Exten(d))

Joint Pain | Biomechanical; Lesion | Knee Inflammation

Spain
Bristol-Myers Squibb

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (TargetTau-1)

Alzheimer Disease, Early Onset

United States, Australia, Belgium, Canada, Denmark, France, Japan, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Sweden, United Kingdom
LB Pharmaceuticals Inc.

Recruiting

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

Schizophrenia

United States
University of Seville

Recruiting

Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT). (BRAINonFIT)

Cognitive Impairment | Executive Dysfunction | Breast Cancer Survivors

Spain
Reata, a wholly owned subsidiary of Biogen

Recruiting

A Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS) (CYPRESS)

Diabetic Peripheral Neuropathic Pain

United States
Eli Lilly and Company

Recruiting

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Cardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or Obesity

United States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia
Laboratorio Elea Phoenix S.A.
Syneos Health

Recruiting

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Non Small Cell Lung Cancer Metastatic

Georgia, Chile, Argentina
Pontificia Universidad Catolica de Chile
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Recruiting

Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

Chile
Centre de l'arthrose, Paris

Recruiting

Inverting Grayscale Improves Detection of Proximal Femur Fracture

Diagnoses Disease

France
Instituto Tecnologico y de Estudios Superiores...

Not yet recruiting

Application of a Nutritional Counseling Program on the Frailty of Older Adults in the Mexican Population

Frailty Syndrome
United Therapeutics

Recruiting

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease

Taiwan, Belgium, Spain, Korea, Republic of, Germany, Australia, Chile, Denmark, France, Mexico, Israel, Italy, Netherlands, Argentina, New Zealand, Peru
Cerevel Therapeutics, LLC

Recruiting

A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

Schizophrenia

United States, Bulgaria, Hungary
Pontificia Universidad Catolica de Chile
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors. (NPQCOVID)

Covid19 | Neurocognitive Dysfunction

Chile
Astellas Pharma Inc

Completed

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

Chronic Renal Failure

Japan
Eli Lilly and Company

Completed

A Study of LY3192767 in Healthy Participants

Healthy

Germany
Astellas Pharma Inc

Completed

Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

Chronic Kidney Disease

Japan
Astellas Pharma Inc

Completed

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis

Japan
Astellas Pharma Inc

Completed

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules

Healthy | Urine Phosphorus Excretion

Japan
Astellas Pharma Inc

Completed

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia

Japan
Hospital Parc Taulí, Sabadell

Unknown

Osteoarthritis Cardiovascular Risk Factors

Cardiovascular Disease | Osteoarthritis | Metabolic Syndrome | Cardiovascular Risk Factors

Spain
Otsuka Pharmaceutical Development & Commercialization...
Novartis

Completed

Study of Rebamipide Eye Drops to Treat Dry Eye

Keratoconjunctivitis Sicca

United States

Search clinical trials for: Bixa orellana

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations